Stanford Women's Cancer Center — Stanford, California

Stanford Women's Cancer Center is a clinical research site located in Stanford, California, United States 94305.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Stanford Women's Cancer Center has participated in 11 clinical trials with 2 currently active.

Therapeutic areas: Advanced Estrogen Receptor Positive HER2- Breast Cancer, Early Breast Cancer, Breast Neoplasms.

Sponsors: Gilead Sciences, Pfizer, AstraZeneca.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Women's Cancer Center?

Stanford Women's Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Women's Cancer Center conducted?

Stanford Women's Cancer Center has 11 clinical trials on record, with 2 currently active. Their work covers Advanced Estrogen Receptor Positive HER2- Breast Cancer, Early Breast Cancer, Breast Neoplasms.

Is Stanford Women's Cancer Center accredited by Crixeo Health?

Yes — Stanford Women's Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Stanford Women's Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.